Ischemic Heart Disease |
|
|
Clinical Trial: Implementation of Ischemic Heart Disease Clinical Practice Guidelines
This study has been completed.
|
Purpose
The purpose of this study is to design and evaluate targeted implementation strategies to fully integrate the VHA clinical practice guidelines for ischemic heart disease into VHA clinical practice. Effectively implementing the guideline will enhance the quality, appropriateness, timeliness, and cost effectiveness of care delivered to veterans with ischemic heart disease. The long-term objective of this study is to identify the best strategies for implementing the IHD guidelines to improve guideline adherence and provider acceptance. The specific objectives of the study are to: (1) describe the temporal aspects of guideline acceptance and adherence, over three periods of time: pre-implementation, post implementation of general strategies, and post- implementation of targeted strategies; (2) assess the relative effectiveness of targeted intervention strategies on guideline adherence; (3) identify the relationships among provider beliefs, attitudes, and their intentions to use guidelines; (4) identify the costs associated with implementation of general and targeted implementation strategies; and (5) describe provider satisfaction with targeted implementation strategies. Qualitative (focus groups, interviews with key informants) and quantitative methods (surveys, chart reviews) are used to address study objectives. A survey will be sent to providers to measure beliefs and attitudes that predict provider acceptance to clinical practice guidelines. Patient level data will be collected from reviews of charts from each facility. Based on provider focus groups we will design targeted strategies to overcome system barriers and address needs identified by providers to support clinical practice guideline implementation. A randomized trial will be conducted to assess the relative effectiveness of the targeted intervention strategies.
| Condition | Treatment or Intervention |
|---|---|
| Myocardial Ischemia Heart Disease Coronary Disease | Device: Personal Digital Assistant (PDA) |
MedlinePlus related topics: Coronary Disease; Heart Diseases; Heart Diseases--Prevention; Vascular Diseases
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Active Control, Single Group Assignment
Expected Total Enrollment: 9789
Study start: October 1999; Study completion: September 2002
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Location Information
Florida
James A. Haley VA Medical Center, Tampa, Florida, 33612, United States
More Information
Record last reviewed: October 2000
Last Updated: October 13, 2004
Record first received: March 14, 2001
ClinicalTrials.gov Identifier: NCT00013104
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- What Is Coronary Artery Disease? (National Heart, Lung and Blood Institute)

Not Signed In -

